Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2725551 | The American Journal of Medicine | 2010 | 7 Pages |
Abstract
Lymphoma patients are at high risk for venous thromboembolism in the initial cycles of chemotherapy; the risk was higher for women, patients with elevated hemoglobin or creatinine, or those receiving doxorubicin or methotrexate. Future studies might focus on validation of these risk factors to identify the high-risk cohort and the potential role of thromboprophylaxis, particularly during initial cycles of chemotherapy.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Xiao MD, PhD, Shyam MD, MPH, Auris PharmD, Yuan PhD, Luis MD, Fredrick B. MD, Gregory MD, Saroj MD,